The normal process for how stakeholders SHOULD work with CMS doesn't make much news or generate big court cases, but it's interesting to see how it can work successfully.
In July 2016, CMS released a special standalone rulemaking specific to a proposed requirement for antibiotic stewardship programs at US hospitals. Here, I reconstruct the back-story as a case study in federal policymaking.
For background see here and here and here. Remember that antimicrobial resistance and better controlled use of antibiotics are major national and global health priorities.
Google helps us reconstruct the tale:
June 2014: Kickoff
In June 2014, the Infectious Diseases Society of America (IDSA), along with the Society for Healthcare Epidemiology of America (SHEA), sent a 20 page letter to CMS asking them to create a "condition of participation" for hospitals that they must have formal antibiotic stewardship programs. See the letter online here.
...Back to 2012
The letter describes multi stakeholder consensus workgroups that go further back, to 2012, and helped support creation of the 2014 request.
...Forward to 2016
Fast forward 24 months, and CMS produced the hospital rule proposal on June 16, 2016 (81 Fed Reg 39448-39480, CMS-3295-P), here. Comment docket here. 201 comments were submitted. I've put about a dozen comments in the cloud as a zip file, highlighting "major" ones with XXX in the file name, here. Interestingly, whereas IDSA and SHEA submitted a joint letter in 2014 requesting the rule, it looks like they commented in 2016 three times: as a joint letter, as a single IDSA letter, and as a single SHEA letter. Other major groups like AHA commented (see zip file).
And Today: 2017-2018
- CMS hasn't finalized the rule yet; one might expect that at 6-12 months, but the agency has up to several years. Perhaps it was viewed as excess regulation by the new administration; perhaps it's in somebody's inbox for sign off.
- Meanwhile, Joint Commission has created guidelines for its hospital accreditation process to help fulfill "best practices" for having an antimicrobial stewardship committee. See JC webpages starting here.
- For an online comparison of the proposed CMS ASP program for hospitals and the finalized JC ASP program for hospitals, see here.
- The JC journal published a February 2018 article (by Cornell authors Kapadia et al.) about how hospitals implement ASP, here; open access.
- A quick search of Pubmed for "antimicrobial stewardship programs" has over 400 hits, here.
- There's a Presidential Council of Advisors for the topic of public health policy and antibiotics, here. (See various work products; the next meeting is May 16).
- CDC is involved in public health and antibiotics, here.
- Lots of stuff at IDSA: enter the IDSA webpages here.
- Based on SSA 1871, the CMS proposed rule issued in June 2016 will expire in June 2019, unless finalized. Right now the June 2016 proposal for future CMS ASP requirements in limbo and in April 2018 inpatient rulemaking, CMS was radio-silent on ASP issues.
I could go on, but the point is, if you view the center of the wheel as the CMS proposed rule in 2016, you can quickly find several years of predecessor and follow-up events that are part of understanding what CMS is thinking.
|click to enlarge|
Not directly related to CMS rulemaking pathways, but see an April 2018 CDC presentation on the ongoing threat of microbial resistance, here here here. The public health issues continue even if the bureaucracy stalls.
Not directly related to CMS rulemaking for antimicrobial stewardship, the same July 2016 rule discussed in this blog also, separately, including several pages of policymaking on healthcare discrimination including transgender topics. For more on that, here.